NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
81 hedge funds and large institutions have $543M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
-3
Holders Change %
-3.57%
% of All Funds
1.64%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
8
Increased
27
Reduced
30
Closed
11
Calls
$215K
Puts
–
Net Calls
+$215K
Net Calls Change
+$202K
Top Buyers
| 1 |
PS
Peter Svennilson
|
$287M |
| 2 |
BlackRock
New York
|
$38.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
$25.6M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
$1.1M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
$4.79M |
